FDA authorized Vela Diagnostics’ Sentosa SQ HIV Genotyping Assay
The Food and Drug Administration has given the go-ahead to what it calls the first next-generation sequencing test for detecting mutations that enable the most common strain of HIV to become immune to drugs. The FDA said that it had authorized
Orion Biotechnology to Initiate Clinical Trials of Its Innovative Microbicide Gel for HIV Prevention
Orion Biotechnology announced that the Polish National Regulatory Agency and Local Ethics Committee have given approval for the OB-002H-101 Phase 1 safety and acceptability study of OB-002H gel to start screening and enrollment. The OB-002H gel is a topical formulation